ESPL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.418200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.637000E-01
Normal-vs-Stage2
5.492000E-01
Normal-vs-Stage3
6.124400E-01
Normal-vs-Stage4
9.526600E-01
Stage1-vs-Stage2
2.648000E-01
Stage1-vs-Stage3
5.929200E-01
Stage1-vs-Stage4
8.943600E-01
Stage2-vs-Stage3
1.688770E-01
Stage2-vs-Stage4
4.331000E-01
Stage3-vs-Stage4
5.320600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.362800E-01
Normal-vs-AfricanAmerican
5.681000E-01
Normal-vs-Asian
7.229200E-01
Caucasian-vs-AfricanAmerican
5.485400E-01
Caucasian-vs-Asian
8.387000E-01
AfricanAmerican-vs-Asian
5.221600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.337400E-01
Normal-vs-Female
6.625000E-01
Male-vs-Female
9.665600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.624600E-01
Normal-vs-Age(41-60Yrs)
6.055800E-01
Normal-vs-Age(61-80Yrs)
6.585200E-01
Normal-vs-Age(81-100Yrs)
6.300200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.683400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.199000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.760600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.059400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.157200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.254200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.868200E-01
Normal-vs-Daily Drinker
7.502000E-01
Normal-vs-Weekly Drinker
6.535600E-01
Normal-vs-Occasional Drinker
7.200800E-01
Normal-vs-Social Drinker
6.198400E-01
Non Drinker-vs-Daily Drinker
9.913200E-01
Non Drinker-vs-Weekly Drinker
6.180600E-01
Non Drinker-vs-Occasional Drinker
9.450400E-01
Non Drinker-vs-Social Drinker
8.221600E-01
Daily Drinker-vs-Weekly Drinker
5.951600E-01
Daily Drinker-vs-Occasional Drinker
9.304600E-01
Daily Drinker-vs-Social Drinker
7.875200E-01
Weekly Drinker-vs-Occasional Drinker
6.601200E-01
Weekly Drinker-vs-Social Drinker
7.644800E-01
Occasional Drinker-vs-Social Drinker
8.590600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.262000E-01
Normal-vs-Grade 2
7.040400E-01
Normal-vs-Grade 3
7.325200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.865600E-02
Grade 1-vs-Grade 3
1.181570E-02
Grade 1-vs-Grade 4
6.262000E-01
Grade 2-vs-Grade 3
4.179000E-01
Grade 2-vs-Grade 4
7.040400E-01
Grade 3-vs-Grade 4
7.325200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.701600E-01
Normal-vs-NonDiabetic
6.253400E-01
Diabetic-vs-NonDiabetic
2.528400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.095600E-01
Normal-vs-NoPancreatitis
7.070800E-01
Pancreatitis-vs-NoPancreatitis
4.195800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.728400E-01
Normal-vs-N1
5.985600E-01
N0-vs-N1
5.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.755960E-01
Normal-vs-TP53-NonMutant
7.023600E-01
TP53-Mutant-vs-TP53-NonMutant
3.798900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
